Login | New Member? Signup Free
ChangeDetect » News

Press Release

Celldex Therapeutics Inc. Posted on:08 Dec 12 Celldex Therapeutics, Inc. today announced final results from the Company’s randomized Phase 2b EMERGE study of CDX-011 in patients with glycoprotein NMB -expressing, advanced, heavily pretreated breast cancer.

Tags: , , , , ,

Seaside granted patent for autism treatment method

A U.S. patent for a drug candidate to improve the social and communication functions in autism was granted to Seaside Therapeutics, Inc., the company announced today.

Tags: , , , ,

USPTO awards Serina patent for polymer drug delivery technology

Serina Therapeutics, Inc., a pharmaceutical research and development company, announced that the company was awarded a patent from the United States Patent and Trademark Office covering its polymer technology. (5 hours ago)

Tags: , , , , , , , , , , , , , , ,

Pfizer ends its cancer vaccine partnership

Pfizer Inc. has backed out of a cancer vaccine program in midstage development, telling partner Celldex Therapeutics Inc. that its strategic priorities have changed.The pharmaceutical giant, with (4 mins ago)

Tags: , , , , , , ,